home / stock / snss / snss news


SNSS News and Press, Viracta Therapeutics Inc Com From 11/30/20

Stock Information

Company Name: Viracta Therapeutics Inc Com
Stock Symbol: SNSS
Market: NASDAQ

Menu

SNSS SNSS Quote SNSS Short SNSS News SNSS Articles SNSS Message Board
Get SNSS Alerts

News, Short Squeeze, Breakout and More Instantly...

SNSS - Sunesis Pharma to merge with Viracta Therapeutics in all-stock deal

Sunesis Pharmaceuticals (SNSS) soars 48% in premarket, after announcing a reverse merger agreement with a privately-held Viracta Therapeutics. The new organization will do business under the Viracta moniker and intends to be listed on the Nasdaq under the ticker symbo...

SNSS - Sunesis Pharmaceuticals and Viracta Therapeutics Announce Definitive Merger Agreement

Merger to c reate Nasdaq-listed company focused on developing Viracta’s precision oncology pipeline targeting virus-associated malignancies Registration trial for Viracta’s lead program in Epstein-Barr virus (EBV)- positive lymph...

SNSS - Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2020 Results - Earnings Call Transcript

Sunesis Pharmaceuticals, Inc. (SNSS) Q3 2020 Results Conference Call November 16, 2020 04:30 PM ET Company Participants Par Hyare - SVP, Commercial Dayton Misfeldt - Dayton Misfeldt Judy Fox - Chief Scientific Officer and EVP, Research & Development Conference Call Participants Justin Kim...

SNSS - Sunesis Pharmaceuticals EPS beats by $0.06

Sunesis Pharmaceuticals (SNSS): Q3 GAAP EPS of -$0.29 beats by $0.06.Cash and equivalents totaled $26M.Shares -0.77%.Press Release For further details see: Sunesis Pharmaceuticals EPS beats by $0.06

SNSS - Sunesis Pharmaceuticals Reports Third Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 16, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today reported financial results for the third quarter ended September 30, 2020. Loss from operations for the three months ended September 30, 2020 was $4.5 million. As...

SNSS - Sunesis Pharmaceuticals to Host Conference Call on November 16th to Discuss Third Quarter 2020 Financial Results and Recent Highlights

SOUTH SAN FRANCISCO, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced that it will host a conference call on Monday, November 16 th , 2020 at 4:30pm Eastern Time to discuss corporate updates and financial results for the third q...

SNSS - GOOG, UAA, SSL and NWL among premarket gainers

Air Industries Group (AIRI) +53% on Q3 results.Equillium (EQ) +24% after FDA gives green signal to it's late-stage COVID-19 trial.BioLineRx (BLRX) +24% on positive late-stage data on lead candidate.Trevena (TRVN) +20%.Miragen Therapeutics (MGEN) +12%.Aldeyra Ther...

SNSS - 4 Penny Stocks To Buy For Under $3.50; What Do Analysts Think?

Does The Price Of These Penny Stocks Matter To These Analysts? Whether you’re a day trader or looking for how to invest in penny stocks certain things are important to keep in mind. First and most important is the risk profile you have. Can you handle big swings in price or d...

SNSS - Sunesis Pharmaceuticals Announces Presentation of SNS-510 Preclinical Data at the 32nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics

SOUTH SAN FRANCISCO, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced a poster presentation at the 32 nd EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics to be held October 24-25, 2020 in a virtual format. ...

SNSS - What's On Your Penny Stocks List This Weekend? 4 To Watch

Are You Watching These 4 Penny Stocks Right Now? Many traders who buy penny stocks for a living tend to hate the weekend. That’s because the market’s closed. But it doesn’t have to be all bad either. Consider this a time to pause, reflect on the week, and look a...

Previous 10 Next 10